Paul J. Mellett
2017
In 2017, Paul J. Mellett earned a total compensation of $1.6M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $142,127 |
|---|---|
| Option Awards | $513,930 |
| Salary | $370,728 |
| Stock Awards | $557,078 |
| Other | $18,551 |
| Total | $1,602,414 |
Mellett received $557.1K in stock awards, accounting for 35% of the total pay in 2017.
Mellett also received $142.1K in non-equity incentive plan, $513.9K in option awards, $370.7K in salary and $18.6K in other compensation.
Rankings
In 2017, Paul J. Mellett's compensation ranked 6,635th out of 14,666 executives tracked by ExecPay. In other words, Mellett earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,635 out of 14,666 | 55th |
Division Manufacturing | 2,456 out of 5,772 | 57th |
Major group Chemicals And Allied Products | 791 out of 2,075 | 62nd |
Industry group Drugs | 610 out of 1,731 | 65th |
Industry Pharmaceutical Preparations | 481 out of 1,333 | 64th |
Source: SEC filing on January 18, 2019.
Mellett's colleagues
We found four more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2017.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019